Skip to main content

COVID-19

By Mallory Hackett | 01:31 pm | July 22, 2021
The move follows recent White House criticism of social media sites for spreading public health misinformation.   
By Adam Ang | 02:36 am | July 22, 2021
The state government of Victoria was found to be the biggest COVID-19-related ad spender during the pandemic.
By Adam Ang | 04:09 am | July 13, 2021
The company claims that the testing solution checks the spectral signature of a virus from a nasal or mouthwash sample to detect COVID-19 within seconds.
By Mallory Hackett | 12:47 pm | July 08, 2021
Individuals with COVID-19 took longer to return to their resting heart rate, sleep and activity baselines than those with symptoms but who tested negative.   
By Nathan Eddy | 02:52 pm | July 01, 2021
The new API is available for governments, providers and authorized third parties in the U.S. 
By Rachel McArthur | 04:38 am | June 23, 2021
G42 Healthcare has partnered with Seegene to offer its new Seegene Mobile Station to various territories across the Middle East and North Africa. Each station can conduct up to 2,000 tests per day.
By Rachel McArthur | 03:17 pm | June 14, 2021
The Abu Dhabi-based company launched the service following requests by patients, it revealed. Starting 15 June, Abu Dhabi will restrict access to public places to those who have been vaccinated against COVID-19, or recently tested negative.
HIMSS21 Europe
By Rosy Matheson | 10:19 am | June 09, 2021
Global healthcare leaders at the #HIMSS21Europe conference have called for the development of self-care apps, the enhancement of digital literacy and the transformation of clinician-patient communication to empower patients to help deliver sustainable healthcare.  
HIMSS21 Europe
By Sara Mageit | 05:32 am | June 09, 2021
Dr Colin Brown, CCIO at the UK's University Hospitals of Morecambe shares the outcomes of using HoloLens mixed reality headset technology to enable practitioners to provide safe and remote clinical services at #HIMSS21Europe. 
SPONSORED
By iXensor* | 12:42 pm | June 07, 2021
A new white paper from HIMSS suggests that the smartphone can hold the key to delivering capacity and enabling an innovative approach to rapid antigen testing as governments continue to wrestle with the impact of the COVID-19 pandemic.